How is Matrix-Bio using metabolite profiling for breast cancer?
Next to skin cancer, breast cancer is the most common form of cancer in women. Early detection is very often the key to survival. Matrix-Bio’s simple blood test may revolutionize how breast cancer is diagnosed and how physicians monitor patients for recurrence of cancer and track the effects of therapy. Using metabolite profiling, MatrixBio is able to identify and measure changes in biomarkers, and in so doing, accurately and reliably detect early stage breast cancer and detect its recurrence after therapy.
